Chemical Structure : Rivasterat
Catalog No.: PC-25025Not For Human Use, Lab Use Only.
Rivasterat (CU06-1004, Sac-1004) is a small molecule vascular leakage blocker and endothelial dysfunction blocker, inhibits endothelial hyperpermeability induced by VEGF, histamine and thrombin via stabilization of cortical actin ring and AJ proteins at the cell-cell junction.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Rivasterat (CU06-1004, Sac-1004) is a small molecule vascular leakage blocker and endothelial dysfunction blocker, inhibits endothelial hyperpermeability induced by VEGF, histamine and thrombin via stabilization of cortical actin ring and AJ proteins at the cell-cell junction.
Treatment of Rivasterat (CU06-1004, Sac-1004) in ECs increased cAMP levels and activated Rac, both of which are known to strengthen endothelial barrier.
Rivasterat (CU06-1004, Sac-1004) blocks vascular leakage by enhancing endothelial integrity via the cAMP/Rac/cortactin pathway.
Rivasterat (CU06-1004, Sac-1004) reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation
Rivasterat (CU06-1004, Sac-1004) inhibited angiogenesis and confirmed vascular stabilization in the oxygen-induced retinopathy model.
M.Wt | 626.83 | |
Formula | C37H54O8 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Zhang H, et al. Exp Mol Med. 2022 Jan;54(1):23-34.
2. Noh M, et al. Eur J Pharmacol. 2023 Jan 15;939:175427.
3. Agrawal V, et al. Oncotarget. 2014 May 15;5(9):2761-77.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright